Mentions
Extended reach
Total likes
Video views
AI synopsis
The posts demonstrate a generally positive sentiment towards the article, highlighting the strong short-term effects of ketamine treatment and referencing real-world clinical success, which shows a high level of engagement. Several discussions focus on detailed aspects like the type of ketamine used and the need for ongoing research, illustrating both interest and active involvement in understanding the implications of the findings.
Most posts express positive views about the evidence supporting ketamine's effectiveness, with some emphasizing clinical success and anecdotal responses.
Discussions show moderate curiosity, especially regarding specific details like the type of ketamine used and long-term strategies.
Posts reference multiple aspects such as meta-analysis, clinical practice, and the need for further research, indicating active engagement.
The social discussions suggest the article influences perceptions around treatment approaches; some call for more widespread consideration and further studies.
@joarhalvorsen For de som er interessert i evidensen: https://t.co/J6kSsZdXUW https://t.co/TK5m7ip6mN https://t.co/vaDi5WFY4z https://t.co/miXnQQnAZv https://t.co/ppqoGKWcMR
@diariodeunloc0 @drlangosta @JRBneuropsiq @dranibalacosta @drbernardong https://t.co/HHpEM0KF3S
@VPrasadMDMPH What type of ketamine was used? I have a feeling they used S ketamine and not a combination of R/S ketamine. Multiple meta-analyses suggest that K is effective, and anecdotally, the patients I've prescribed it to have responded extremely well. https://t.co/GNSwEUDKv5
@ProfRobHoward @alokvkulkarni @shyambhat @lena_pl For IV ketamine, the meta-analyzed effect size of single-dose trials is very large (latest of 8 here). The problem is that there is little study of maintenance strategies after a short series of infusions. https://t.co/vDMqG5sneR https://t.co/wITP1RTAfE
@joannamoncrieff Meta-analysis needed to be read https://t.co/No3uxZBY08 But most, U need to see patients who benefit from these treatment in Psychiatry I have seen the spectacular efficacy during this last 7yrs in patients with depression or suicidal ideation @rogersmcintyre any comment ?
RT @andreas_wahl: @joarhalvorsen For de som er interessert i evidensen: https://t.co/J6kSsZdXUW https://t.co/TK5m7ip6mN https://t.co/vaDi…
Numerous studies show that ketamine can work as a fast-acting antidepressant alleviating symptoms in a matter of hours or days. It provides quick relief of depressive symptoms, especially within 24 hours of infusion…
This video reviews the history and emerging role of psychedelics in psychiatry. It discusses research on ketamine-assisted therapy, psilocybin, and their applications in treating PTSD, depression, and…
This episode of the Ketamine Startup Podcast shares insights on opening a ketamine clinic, discussing the efficacy of IV ketamine for mental health issues. Learn about treatment resistance, especially in depression, and…
This episode covers the journey of opening a ketamine clinic with insights from a presentation by Sam at the ACEP Scientific Assembly. Learn about the efficacy of IV ketamine for treatment-resistant depression, anxiety…
@ArtCandee @donlemon It's got strong clinical rationale, alongside a number of psychoactive substances under review at John Hopkins. Here is some meta analysis on the topic: https://t.co/ur6Xo4GXGd
@VPrasadMDMPH What type of ketamine was used? I have a feeling they used S ketamine and not a combination of R/S ketamine. Multiple meta-analyses suggest that K is effective, and anecdotally, the patients I've prescribed it to have responded extremely well. https://t.co/GNSwEUDKv5
RT @andreas_wahl: @joarhalvorsen For de som er interessert i evidensen: https://t.co/J6kSsZdXUW https://t.co/TK5m7ip6mN https://t.co/vaDi…
RT @andreas_wahl: @joarhalvorsen For de som er interessert i evidensen: https://t.co/J6kSsZdXUW https://t.co/TK5m7ip6mN https://t.co/vaDi…
RT @andreas_wahl: @joarhalvorsen For de som er interessert i evidensen: https://t.co/J6kSsZdXUW https://t.co/TK5m7ip6mN https://t.co/vaDi…
RT @andreas_wahl: @joarhalvorsen For de som er interessert i evidensen: https://t.co/J6kSsZdXUW https://t.co/TK5m7ip6mN https://t.co/vaDi…
@joarhalvorsen For de som er interessert i evidensen: https://t.co/J6kSsZdXUW https://t.co/TK5m7ip6mN https://t.co/vaDi5WFY4z https://t.co/miXnQQnAZv https://t.co/ppqoGKWcMR
@morsmorded >хоч якогось наукового підґрунтя https://t.co/usPSMT8out https://t.co/A7Dr0qOwxQ https://t.co/a8HPjNvgW5 https://t.co/DFQCm5svMR https://t.co/WrLOSpVGfo https://t.co/DDPmluAa44 ..і ще мільйон наукових статей, які загалом доводять що ви несете дурню, яку, схоже, самі і вигадали https://t.co/Yyu1bAUWLs
@joannamoncrieff Meta-analysis needed to be read https://t.co/No3uxZBY08 But most, U need to see patients who benefit from these treatment in Psychiatry I have seen the spectacular efficacy during this last 7yrs in patients with depression or suicidal ideation @rogersmcintyre any comment ?
@MalaWolf To burde vel holde for nå… https://t.co/UHKQsJxT0t https://t.co/QkUIxE5bUt
@ProfRobHoward @alokvkulkarni @shyambhat @lena_pl For IV ketamine, the meta-analyzed effect size of single-dose trials is very large (latest of 8 here). The problem is that there is little study of maintenance strategies after a short series of infusions. https://t.co/vDMqG5sneR https://t.co/wITP1RTAfE
@diariodeunloc0 @drlangosta @JRBneuropsiq @dranibalacosta @drbernardong https://t.co/HHpEM0KF3S